|
Volumn 87, Issue 3, 2001, Pages 201-204
|
Tolerability to new COX-2 inhibitors in NSAID-sensitive patients with cutaneous reactions
a,b a a c |
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETYLSALICYLIC ACID;
CELECOXIB;
CYCLOOXYGENASE 1;
CYCLOOXYGENASE 2;
CYCLOOXYGENASE 2 INHIBITOR;
DICLOFENAC;
FLURBIPROFEN;
GLAFENINE;
IBUPROFEN;
KETOPROFEN;
KETOROLAC;
MEFENAMIC ACID;
MELOXICAM;
NIMESULIDE;
NONSTEROID ANTIINFLAMMATORY AGENT;
OCTAFENIN;
PARACETAMOL;
PIROXICAM;
PYRAZOLONE;
ROFECOXIB;
SULINDAC;
TIAPROFENIC ACID;
UNCLASSIFIED DRUG;
ADOLESCENT;
ADULT;
AGED;
ANALGESIA;
ANGIONEUROTIC EDEMA;
ANTIINFLAMMATORY ACTIVITY;
ARTICLE;
CLINICAL FEATURE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CROSS REACTION;
DRUG HYPERSENSITIVITY;
DRUG MECHANISM;
DRUG SAFETY;
DRUG TOLERABILITY;
FEMALE;
HUMAN;
INFLAMMATION;
MAJOR CLINICAL STUDY;
MALE;
PRIORITY JOURNAL;
PROVOCATION;
RANDOMIZED CONTROLLED TRIAL;
RISK BENEFIT ANALYSIS;
SCHOOL CHILD;
SINGLE BLIND PROCEDURE;
URTICARIA;
|
EID: 0034823297
PISSN: 10811206
EISSN: None
Source Type: Journal
DOI: 10.1016/S1081-1206(10)62226-0 Document Type: Article |
Times cited : (122)
|
References (15)
|